Sequent Scientific has informed that they referred to the news item in Economic Times on July 27, 2015 titled Sequent Unit set to buy Mumbai based Lykas veterinary business. Sequent has a stated strategic intent of creating a global powerhouse in animal health business through its subsidiary Alivira Animal Health Ltd. Towards this objective, the Company continues to explore and evaluate strategic growth opportunities, including inorganic opportunities. Whenever, there is any event or information that will have a significant bearing on the performance of the Company or any price-sensitive event, they will promptly inform the stock exchanges. Company has nothing specific to report at this point of time.
The above information is a part of company’s filings submitted to BSE.
